# US Catheters Active Implantable CDMO Market > US Catheters Active Implantable CDMO Market Research Report By Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, Others) and By End-Users (Medical Device OEM Companies, Academic and Research Institutes, Government Agencies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.71% - **2024:** $ 1,730 Million - **2025:** $ 1,915.28 Million - **2035:** $ 5,300 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Teleflex Incorporated (US), Cook Medical (US), Smiths Medical (US), ConvaTec Group (GB) **Report ID:** MRFR/MED/48485-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-catheters-active-implantable-cdmo-market-50242 --- ## Market Summary ## **US Catheters Active Implantable CDMO Market Overview** As per MRFR analysis, the US Catheters Active Implantable CDMO Market Size was estimated at 1.7 (USD Billion) in 2023. The US Catheters Active Implantable CDMO Market Industry is expected to grow from 1.83(USD Billion) in 2024 to 7.74 (USD Billion) by 2035. The US Catheters Active Implantable CDMO Market CAGR (growth rate) is expected to be around 13.974% during the forecast period (2025 - 2035). ## **Key US Catheters Active Implantable CDMO Market Trends Highlighted** The US Catheters Active Implantable CDMO Market is currently experiencing important changes influenced by several reasons. One of the foremost factors propelling the market is the heightened cases of chronic ailments such as diabetes and cardiovascular diseases which are critical and require specialized medical technologies for their proper patient management. This increase in health problems is causing a lot of issues for the healthcare providers which is forcing them to look for new solutions.  This has also increased the demand for active implantable catheters. In addition to that, the US market is also benefitting from the increasing elderly population as older people tend to need a greater number of medical devices and interventions, increasing the disease burden. Focusing on advancements of catheter technology such as the addition of smart devices and the creation of biocompatible materials provides the US market with opportunities to be beneficial. Along with that, the shift toward minimally invasive procedures is making it easier for CDMO businesses that focus on the design and manufacture of catheters to enter the market. Moreover, the strong support of the FDA towards novel technologies for medical devices makes it easier for manufacturers to focus on research and development.  This leads to a lot of possibilities for technological developments and launching new products. Recently, there has been a clear shift to personalized medicines where healthcare experts provide individualized solutions to the patients rather than broad methods. In addition to improving patient outcomes, this strategy enables CDMO companies to partner with providers at a deeper level. In addition, changes to regulations and simpler pathways to approval for new medical devices are providing even more acceleration to growth within the industry towards lower barriers to entry into the market. All in all, the interrelationship of technological advancements and demands from the healthcare system is the primary reason for driving the rapid development of the US Catheters Active Implantable CDMO Market. $IMAGE1_HERE$ ## **US Catheters Active Implantable CDMO Market Drivers** Increasing prevalence of chronic diseases The rise in chronic diseases such as diabetes and heart conditions is a significant driver for the US Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market. According to the Centers for Disease Control and Prevention (CDC), as of 2021, 6 in 10 adults in the United States have a chronic disease, and 4 in 10 have two or more chronic diseases. This growing patient population increases the demand for advanced catheter devices used in managing these conditions. Organizations like Medtronic and Boston Scientific are investing heavily in the Research and Development of innovative catheter solutions tailored for these chronic ailments, enhancing their product offerings and market reach. This trend is likely to significantly boost the US Catheters Active Implantable CDMO Market Industry, as tailored, effective catheter solutions are critical in managing chronic diseases, leading to an increasing market size and growth rate. Technological advancements in catheter design Technological innovations in catheter design, such as the development of biocompatible materials and minimally invasive techniques, are pivotal in augmenting the US Catheters Active Implantable CDMO Market. Advancement in materials science has led to the production of catheters that reduce the risk of infection and improve patient outcomes. For instance, a study published by the Journal of Vascular Interventional Radiology indicated that advanced materials used in catheter production have reduced complications by up to 30%. Companies like Cook Medical are at the forefront of such advancements, continually pushing the limits of innovation. These improvements not only enhance safety and effectiveness but are also driving wider adoption of catheters across various medical fields, further stimulating the US Catheters Active Implantable CDMO Market Industry. Growing elderly population The aging population in the United States is significantly impacting the US Catheters Active Implantable CDMO Market. As per the Administration for Community Living (ACL), the number of American seniors aged 65 and older is projected to reach 94.7 million by 2060, representing about 23% of the total US population. Older adults generally have a higher incidence of illnesses requiring catheterization, leading to increased demand for catheter devices. Companies such as Johnson & Johnson are actively targeting this demographic through specialized products and marketing strategies that meet the unique needs of elderly patients. The trend of an aging population is creating a sustainable growth trajectory for the US Catheters Active Implantable CDMO Market Industry as healthcare providers innovate to cater to this expanding demographic. ## **US Catheters Active Implantable CDMO Market Segment Insights** ### **Catheters Active Implantable CDMO Market Service Category Insights** The Service Category segment of the US Catheters Active Implantable CDMO Market reveals a diversified landscape where various medical technologies play pivotal roles in patient care and procedural success. Catheters serve as essential tools in numerous medical applications, including cardiovascular interventions and fluid management, demonstrating their foundational importance in healthcare settings across the US. Active Implantable Devices are equally critical, offering innovative solutions such as pacemakers and neurostimulators, which significantly enhance the quality of life for individuals with chronic health conditions. The rise of Endoscopy Devices within this segment indicates a trend towards minimally invasive procedures, aligning with the ongoing shift in the US healthcare industry towards patient-centric care and reduced recovery times. Other devices within this category further contribute to market growth by addressing specific medical needs and advancing therapeutic procedures. Enhanced R&D efforts and technology integration are driving factors, leading to superior materials and designs that improve efficacy and safety. However, challenges such as regulatory hurdles and market competition persist, influencing the pace of innovation. The overall dynamics of the US Catheters Active Implantable CDMO Market segmentation highlight growth opportunities, particularly in personalized medicine and technologically advanced devices. The evolving regulations and healthcare policies in the US continue to shape the industry framework, presenting a demand for compliance and elevated product standards, which can drive service category innovations. Overall, this segment is a vital component of the market, underlining the critical interplay of technology, patient care, and regulatory environments in shaping the future of medical device manufacturing and associated services in the United States. $IMAGE2_HERE$ ### **Catheters Active Implantable CDMO Market End-Users Insights** The End-Users segment of the US Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market plays a crucial role in driving innovation and adoption of advanced catheter technologies. This sector is primarily comprised of Medical Device Original Equipment Manufacturers (OEM) Companies, Academic and Research Institutes, and Government Agencies, each contributing uniquely to the overall ecosystem. Medical Device OEM Companies lead the charge, focusing on developing cutting-edge catheter solutions that enhance patient outcomes, while maintaining compliance with stringent regulatory standards. Academic and Research Institutes significantly contribute by conducting vital Research and Development activities, aiming to explore new materials and technologies that can improve catheter performance and safety. Additionally, Government Agencies, through regulatory frameworks and funding for innovative projects, ensure that advancements in the catheter industry adhere to public health guidelines. This collaboration among different stakeholders fosters a dynamic environment that enhances the US Catheters Active Implantable CDMO Market, enabling continuous market growth while responding to evolving healthcare needs. Collectively, these End-Users are vital in creating a stable foundation for advancements in catheter technology and overall medical device innovation in the United States. **US Catheters Active Implantable CDMO Market Key Players and Competitive Insights:** The US Catheters Active Implantable CDMO Market is characterized by a dynamic competitive landscape driven by advancements in technology and increasing demand for high-quality medical devices. Contract development and manufacturing organizations (CDMO) play a crucial role in this sector, facilitating efficient production and innovation of catheter-based solutions that cater to various medical needs.  As the healthcare industry consistently evolves, particularly in the realm of minimally invasive procedures, the emphasis on collaboration between manufacturers and CDMOs continues to intensify, fostering innovation and enhancing market penetration. Companies within this market are continually adapting to regulatory changes and patient needs, while striving to deliver superior products. Cook Medical holds a significant position in the US Catheters Active Implantable CDMO Market, leveraging its advanced capabilities and longstanding industry experience. Cook Medical is recognized for its robust portfolio of catheter solutions, which are tailored for different medical applications including urological, cardiovascular, and neurovascular interventions. The company’s regional presence is marked by strong distribution networks that ensure accessibility to healthcare providers and patients alike.  One of the key strengths of Cook Medical lies in its commitment to innovation, which is evident in its investments in research and development aimed at enhancing the design and functionality of catheter products. Furthermore, the company places a strong emphasis on quality assurance and regulatory compliance, thereby instilling confidence among its clients. Johnson & Johnson is another major player in the US Catheters Active Implantable CDMO Market, boasting an extensive portfolio that includes notable products such as advanced catheters for electrophysiology, vascular interventions, and surgical applications. The company's strong market presence is enhanced by its well-established brand reputation and extensive distribution channels across the United States. Notably, Johnson & Johnson's strengths include its rigorous approach to quality control, extensive research and development initiatives, and a commitment to addressing the evolving demands of the healthcare landscape.  In recent years, the company has focused on strategic mergers and acquisitions, further strengthening its position in the market and expanding its product offerings. This proactive approach allows Johnson & Johnson to not only maintain its competitive edge but also drive innovation in the active implantable catheter space, ensuring that it remains at the forefront of medical technology in the US. **Key Companies in the US Catheters Active Implantable CDMO Market Include:** **US Catheters Active Implantable CDMO Market Industry Developments** The US Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market has witnessed notable developments in recent months. Companies such as Cook Medical and Boston Scientific have been expanding their product portfolios to enhance patient outcomes. In June 2023, Johnson and Johnson acquired a smaller medical device company to complement their existing catheter line, aiming to boost their competitive edge. Smiths Medical has been focusing on Research and Development to improve the efficacy of their catheter systems. Current market trends indicate an increase in demand for advanced catheter technologies, spurred by an aging population and growing prevalence of chronic diseases.  Furthermore, in September 2023, Medtronic announced a strategic partnership with Teleflex to co-develop next-generation catheter systems, indicating strong collaborative efforts in the sector. Market valuation has grown significantly, with analysts projecting an uptick due to innovation and steady investments from Fresenius Kabi and Abbott Laboratories. Over the last two years, the US catheter market has registered significant growth driven by advancements in technology and manufacturing processes, with key players vying for market share through mergers and acquisitions to enhance operational capabilities. ## **Catheters Active Implantable Cdmo Market Segmentation Insights** ### **Catheters Active Implantable CDMO Market Service Category Outlook** ### **Catheters Active Implantable CDMO Market End-Users Outlook** ## Market Drivers ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases such as cardiovascular disorders, diabetes, and renal failure is a primary driver for the catheters active-implantable-cdmo market. As these conditions often necessitate the use of catheters for treatment and management, the demand for innovative catheter solutions is likely to rise. According to recent data, chronic diseases affect nearly 60% of the adult population in the US, leading to a substantial market opportunity. The need for effective management of these diseases through catheterization is expected to propel the growth of the market, as healthcare providers seek advanced solutions to improve patient outcomes. This trend indicates a robust demand for catheters that are not only effective but also designed for long-term use, thereby enhancing the overall market landscape. ### Growing Demand for Home Healthcare Solutions The shift towards home healthcare solutions is emerging as a significant driver for the catheters active-implantable-cdmo market. As patients increasingly prefer receiving care in the comfort of their homes, the demand for portable and user-friendly catheter systems is likely to grow. This trend is supported by the aging population and the rising prevalence of chronic conditions that require ongoing management. It is estimated that the home healthcare market will expand at a CAGR of 10% over the next few years, creating opportunities for catheter manufacturers to develop products tailored for home use. This shift not only enhances patient convenience but also reduces healthcare costs, thereby influencing the overall market dynamics. ### Technological Innovations in Catheter Design Technological advancements in catheter design and materials are significantly influencing the catheters active-implantable-cdmo market. Innovations such as biocompatible materials, smart catheters with integrated sensors, and enhanced delivery systems are becoming increasingly prevalent. These advancements not only improve the functionality and safety of catheters but also cater to the growing demand for personalized medicine. The market is projected to witness a growth rate of approximately 8% annually, driven by these innovations. As manufacturers invest in research and development to create next-generation catheters, the market is likely to expand, offering healthcare providers more effective tools for patient care. This focus on innovation is essential for maintaining competitiveness in the evolving landscape of medical devices. ### Increased Investment in Healthcare Infrastructure The ongoing investment in healthcare infrastructure in the US is a crucial driver for the catheters active-implantable-cdmo market. With the expansion of hospitals, outpatient facilities, and specialized clinics, the demand for advanced medical devices, including catheters, is expected to rise. Recent reports indicate that healthcare spending in the US is projected to reach $4 trillion by 2025, reflecting a growing commitment to improving patient care. This investment not only enhances the availability of medical services but also encourages the adoption of innovative catheter technologies. As healthcare facilities upgrade their equipment and services, the catheters active-implantable-cdmo market stands to benefit from increased procurement of advanced catheter solutions. ### Regulatory Support for Innovative Medical Devices Regulatory support for the development and approval of innovative medical devices is a vital driver for the catheters active-implantable-cdmo market. The US Food and Drug Administration (FDA) has implemented streamlined processes for the approval of advanced catheter technologies, facilitating quicker market entry for new products. This regulatory environment encourages manufacturers to invest in research and development, fostering innovation within the industry. As a result, the market is likely to see a surge in the introduction of novel catheter solutions that meet evolving healthcare needs. The proactive stance of regulatory bodies in supporting innovation is expected to enhance the competitive landscape of the catheters active-implantable-cdmo market. ## Future Outlook The [Catheters Active Implantable CDMO Market](https://www.marketresearchfuture.com/reports/catheters-active-implantable-cdmo-market-26788) is projected to grow at a 10.71% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of customized catheter solutions for niche medical applications. - Expansion of telehealth services integrating catheter management. - Investment in biodegradable materials for sustainable catheter production. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Service Segment: Catheters (Largest) vs. Active Implantable Devices (Fastest-Growing) In the US catheters active-implantable-cdmo market, the service segment is prominently divided among three key categories: Catheters, Active Implantable Devices, and Endoscopy Devices. Among these, Catheters hold the largest market share, showcasing their established role in various medical applications. Active Implantable Devices, while smaller in overall market share compared to Catheters, are rapidly gaining traction, indicating a dynamic shift in industry focus. Growth trends in this segment are primarily driven by increasing healthcare demands and technological advancements. Catheters, as the dominant segment, benefit from their essential use in procedures such as vascular access and urinary management. Conversely, the rising prevalence of chronic diseases is propelling the expansion of Active Implantable Devices, which offer innovative solutions for patient care. This competitive environment necessitates continual evolution and investment in both segments. Catheters (Dominant) vs. Active Implantable Devices (Emerging) Catheters are a dominant force in the US catheters active-implantable-cdmo market due to their crucial role in multiple therapeutic areas, including vascular interventions and urinary management. Their longstanding utility has solidified their position as the leading choice among healthcare providers. On the other hand, Active Implantable Devices represent an emerging segment characterized by advanced technologies, such as implantable cardioverter-defibrillators and neurostimulators. These devices are increasingly sought after for their innovative designs and capabilities in managing chronic conditions. With a focus on patient outcomes, the growing demand for these devices reflects a shift towards minimally invasive solutions, driving further investment and development in this segment. ### By End User: Medical Device OEM Companies (Largest) vs. Academic and Research Institutes (Fastest-Growing) In the US catheters active-implantable-cdmo market, the distribution of market share among the end user segments shows that Medical Device OEM Companies hold the largest share, significantly driving the market dynamics. This segment benefits from established relationships with manufacturers and a high demand for innovative catheter technologies that meet regulatory standards. In contrast, Academic and Research Institutes represent the fastest-growing segment, reflecting a surge in research activities and funding aimed at developing advanced medical solutions and technologies that cater to patient needs in this sector. Growth trends in this market segment indicate that Medical Device OEM Companies are expanding their product portfolios to include high-performance catheters that enhance patient outcomes. Meanwhile, Academic and Research Institutes are experiencing robust growth fueled by increased collaboration with industry stakeholders, advancing medical research, and a focus on pioneering catheter designs. This dual trend illustrates the synergy between established industrial players and emerging academic insights that shape the future landscape of the market. Medical Device OEM Companies (Dominant) vs. Academic and Research Institutes (Emerging) Medical Device OEM Companies are recognized as the dominant force in the US catheters active-implantable-cdmo market, leveraging their extensive distribution networks and experience in manufacturing high-quality catheters. These companies prioritize innovation and regulatory compliance, which positions them to address evolving healthcare demands effectively. On the other hand, Academic and Research Institutes have emerged as vital players, focusing on cutting-edge research and development. They foster a collaborative ecosystem with industry partners that enhances the transition of laboratory innovations into commercially viable products, thereby playing a crucial role in the advancement of catheter technologies and ultimately influencing the market's future direction. ## Competitive Benchmarking The catheters active-implantable-cdmo market in the US exhibits a dynamic competitive landscape, characterized by rapid innovation and strategic collaborations among key players. Major companies such as Medtronic (US), Boston Scientific (US), and Abbott (US) are at the forefront, leveraging their extensive research capabilities and established market presence to drive growth. Medtronic (US) focuses on enhancing its product portfolio through technological advancements, while Boston Scientific (US) emphasizes strategic partnerships to expand its market reach. Abbott (US) appears to prioritize digital transformation, integrating advanced data analytics into its operations to improve patient outcomes and operational efficiency. Collectively, these strategies contribute to a competitive environment that is increasingly driven by innovation and collaboration.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain resilience and reduce operational costs. This trend is particularly evident in the moderately fragmented market structure, where the collective influence of key players shapes competitive dynamics. The emphasis on supply chain optimization is critical, as it allows companies to respond swiftly to market demands and regulatory changes, thereby maintaining a competitive edge. In October Medtronic (US) announced a strategic partnership with a leading technology firm to develop AI-driven catheter systems aimed at improving procedural accuracy and patient safety. This collaboration underscores Medtronic's commitment to innovation and positions it to capitalize on the growing demand for advanced medical devices. The integration of AI technology is likely to enhance product differentiation and strengthen Medtronic's market position. In September Boston Scientific (US) expanded its manufacturing capabilities by investing in a new facility in the Midwest, aimed at increasing production capacity for its catheter products. This move not only reflects Boston Scientific's strategy to meet rising demand but also highlights its focus on regional expansion. By enhancing local production, the company can better serve its customer base while optimizing logistics and reducing lead times. In August Abbott (US) launched a new line of catheters designed for minimally invasive procedures, which incorporates advanced materials to improve flexibility and reduce patient recovery time. This product introduction aligns with Abbott's strategy to innovate within the active-implantable space, catering to the growing preference for less invasive surgical options. The launch is expected to bolster Abbott's competitive position by addressing evolving market needs and enhancing patient care. As of November current trends in the catheters active-implantable-cdmo market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, product innovation, and supply chain reliability. This shift suggests that companies that prioritize these areas will be better positioned to thrive in an increasingly complex market. ## Recent News & Developments The US Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market has witnessed notable developments in recent months. Companies such as Cook Medical and Boston Scientific have been expanding their product portfolios to enhance patient outcomes. In June 2023, Johnson and Johnson acquired a smaller medical device company to complement their existing catheter line, aiming to boost their competitive edge. Smiths Medical has been focusing on Research and Development to improve the efficacy of their catheter systems. Current market trends indicate an increase in demand for advanced catheter technologies, spurred by an aging population and growing prevalence of chronic diseases.  Furthermore, in September 2023, Medtronic announced a strategic partnership with Teleflex to co-develop next-generation catheter systems, indicating strong collaborative efforts in the sector. Market valuation has grown significantly, with analysts projecting an uptick due to innovation and steady investments from Fresenius Kabi and Abbott Laboratories. Over the last two years, the US catheter market has registered significant growth driven by advancements in technology and manufacturing processes, with key players vying for market share through mergers and acquisitions to enhance operational capabilities. ## Report Scope | MARKET SIZE 2024 | 1730.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1915.28(USD Million) | | MARKET SIZE 2035 | 5300.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.71% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Teleflex Incorporated (US), Cook Medical (US), Smiths Medical (US), ConvaTec Group (GB) | | Segments Covered | Service Segment, End User | | Key Market Opportunities | Advancements in biocompatible materials enhance innovation in the catheters active-implantable-cdmo market. | | Key Market Dynamics | Rising demand for innovative catheter technologies drives competition among active-implantable contract development and manufacturing organizations. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the market valuation of the US catheters active-implantable-cdmo market in 2024?** A: The market valuation was $1730.0 Million in 2024. **Q: What is the projected market valuation for the US catheters active-implantable-cdmo market by 2035?** A: The projected valuation for 2035 is $5300.0 Million. **Q: What is the expected CAGR for the US catheters active-implantable-cdmo market during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 10.71%. **Q: Which companies are considered key players in the US catheters active-implantable-cdmo market?** A: Key players include Medtronic, Boston Scientific, Abbott, Johnson & Johnson, B. Braun Melsungen AG, Teleflex Incorporated, Cook Medical, Smiths Medical, and ConvaTec Group. **Q: What are the segment valuations for catheters in the service segment?** A: The segment valuation for catheters in the service segment ranges from $600.0 Million to $1800.0 Million. **Q: What is the valuation range for active implantable devices in the service segment?** A: The valuation range for active implantable devices in the service segment is from $800.0 Million to $2500.0 Million. **Q: How much is the end user segment for medical device OEM companies valued at?** A: The end user segment for medical device OEM companies is valued between $600.0 Million and $1800.0 Million. **Q: What is the valuation range for government agencies in the end user segment?** A: The valuation range for government agencies in the end user segment is from $730.0 Million to $2300.0 Million. **Q: What is the valuation range for endoscopy devices in the service segment?** A: The valuation range for endoscopy devices in the service segment is from $330.0 Million to $1000.0 Million. **Q: How do the projected growth figures for the US catheters active-implantable-cdmo market compare to its 2024 valuation?** A: The projected growth figures indicate a substantial increase from $1730.0 Million in 2024 to $5300.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-catheters-active-implantable-cdmo-market-50242*